Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
23.45
-0.48 (-2.01%)
Feb 27, 2026, 4:00 PM EST - Market closed

Tectonic Therapeutic Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
439390681---
Market Cap Growth
-5.85%-42.68%----
Enterprise Value
186123525---
Last Close Price
23.4520.8646.17---
PB Ratio
1.751.554.84---
P/TBV Ratio
1.751.554.84---
Debt / Equity Ratio
0.010.010.02-1.080.170.04
Net Debt / Equity Ratio
-1.00-1.00-0.986.09-0.86-0.98
Net Debt / EBITDA Ratio
3.063.062.450.570.951.77
Net Debt / FCF Ratio
4.194.192.330.601.011.85
Quick Ratio
26.2626.2612.170.704.596.82
Current Ratio
26.6326.6312.650.764.736.95
Return on Equity (ROE)
-37.82%-37.82%-84.79%-276.60%-102.77%-
Return on Assets (ROA)
-25.38%-25.38%-37.71%-64.44%-51.24%-
Return on Capital Employed (ROCE)
-33.40%-33.40%-41.10%2998.50%-83.40%-54.30%
Earnings Yield
-16.89%-18.99%-8.51%---
FCF Yield
-13.74%-15.44%-8.70%---
Buyback Yield / Dilution
-115.81%-115.81%-569.30%49.78%--
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q